AtriCure, Inc. (ATRC) Earnings Call Transcript & Summary

Good morning, and welcome to the AtriCure, Inc. 2021 Annual Meeting of Stockholders. I would now like to introduce the first presenter, Mike Carrel, President and CEO of AtriCure.

Thank you, and good morning, everyone. Welcome to the 2021 Annual Meeting of Stockholders for AtriCure. I'm Mike Carrel, President and CEO and also a member of the Board of Directors. On behalf of our entire Board, our officers and employees, I'd like to thank you for attending this meeting. We are conducting this meeting virtually so that our shareholders can participate regardless of their geographic location as we continue to place health and safety of our stockholders and employees above all else. As a reminder, the agenda and rules of conduct for today's meeting are posted on this meeting's website. Following the conclusion of my remarks, there will be a brief opportunity for questions about the proxy items voted upon during this meeting. These questions from stockholders may be submitted in the text box field provided on the web portal during the meeting. We are asking stockholders who submit a question to include their name and e-mail address as well. If you submit a question and we do not have an opportunity to answer it at this meeting, someone from AtriCure will follow up with you soon after the meeting. All other questions can be addressed by calling Angie Wirick, our Chief Financial Officer at any time. I would now like to introduce the other members of our Board of Directors: Mark Collar, Scott Drake, Dan Florin, Reggie Groves, Kris Johnson, Mark Lanning, Karen Prange, Sven Wehrwein and Bob White. Now turning to the 3 proposals for consideration by stockholders, all of which are fully described in the proxy statement. Proposal #1. Our first proposal is the election of 8 directors to hold office for 1 year or until a successor is duly elected and qualified. The nominees are Mark Collar, Dan Florin, Reggie Groves, Kris Johnson, Karen Prange, Sven Wehrwein and Bob White and myself. Proposal #2. The second proposal is the ratification of the appointment of the company's independent registered public accounting firm. Although the audit committee has the sole authority to appoint the company's auditors, the committee would like to know the opinion of stockholders regarding its appointment of Deloitte as the auditor for 2021. Proposal #3. The third proposal relates to an advisory vote on the compensation of our named executive officers. This proposal is required by the Dodd-Frank Wall Street Reform and Consumer Act -- Protection Act and is referred to as the say-on-pay vote. We ask that stockholders approve, on an advisory basis, the compensation for our named executive officers as disclosed in the proxy statement. [Voting]

I'm pausing in case there are any questions, I do not see any questions. Since there are no questions or comments and the voting is now closed, I would like to report the voting results, all of which are subject to a final tabulation. Approximately 95% or over 43 million shares of the approximately 45 million shares outstanding have been voted. All 8 nominees proposed by the Board of Directors were elected. With respect to proposals to ratify the appointment of our independent registered public accounting firm and approve the compensation of our named executive officers on an advisory basis, both have been approved. Since there is no other business to conduct at this meeting, I declare the meeting adjourned. Thank you, and have a wonderful day.

Thank you. The annual general meeting for AtriCure has now come to an end. Thank you for attending. You may now leave the virtual meeting.